(Q44369841)

2 December 2017

title

An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease (English)

1 reference

2 December 2017

0 references

1 reference

Hanna Rosenmann

1

1 reference

2 December 2017

Zeev Meiner

2

1 reference

2 December 2017

Esther Kahana

3

1 reference

2 December 2017

Zoja Aladjem

4

1 reference

2 December 2017

Gideon Friedman

5

1 reference

2 December 2017

Arie Ben-Yehuda

6

1 reference

2 December 2017

Tal Grenader

7

1 reference

2 December 2017

Eli Wertman

8

1 reference

2 December 2017

Oded Abramsky

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

2 December 2017

volume

340

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

29-32

1 reference

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

A simple and efficient method for apolipoprotein E genotype determination

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

p53 gene polymorphism and cancer risk: the debate continues

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

p53; from inductive signal to cellular effect

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Genetic susceptibility to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

p53 polymorphisms and haplotypes show distinct differences between major ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Evidence for apoptotic cell death in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Immunohistochemical evidence for apoptosis in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

New frontiers in Alzheimer's disease genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900049-1

7 January 2021

10.1016/S0304-3940(03)00049-1

Identifiers

DOI

1 reference

2 December 2017

1 reference